Company News, Financial News

Johnson & Johnson’s Total Sales Grow 10.7% to $23.3 Billion in Q3

The personal care giant demonstrated responsiveness to meet the needs of stakeholders in the face of evolving marketplace dynamics as a result of Covid-19.

Author Image

By: Lianna Albrizio

Associate Editor

Johnson & Johnson’s Q3 sales grew 10.7% to $23.3 billion. Earnings per share of $1.37 increased to 3.0%, and adjusted earnings per share of $2.60 increased to 18.2%.   “Our third-quarter results demonstrate solid performance across Johnson & Johnson, driven by robust above-market results in pharmaceuticals, ongoing recovery in medical devices, and strong growth in consumer health,” said Alex Gorsky, chairman and chief executive officer. “In the face of evolving ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters